감염증 진단 검사 시장 규모는 향후 몇 년 동안 빠르게 성장하여 2029년에는 연평균 10.1%의 CAGR로 625억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 신종 인플루엔자 및 COVID-19와 같은 신종 병원체의 지속적인 출현, 맞춤형 의료 및 표적 치료로의 전환, 신속한 현장 검사 솔루션에 대한 수요 증가, 역학 감시 및 조기 발견 시스템에 대한 중요성 증가, 새로운 진단 기술 및 바이오 마커 개발에 초점을 맞춘 연구 및 개발이 주도할 것으로 예상됩니다. 바이오 마커 개발에 초점을 맞춘 연구개발 활동의 활성화 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 진단 기기의 소형화 및 휴대성 향상, 여러 병원체를 동시에 검출할 수 있는 멀티플렉스 분석법 채택, 모바일 앱 및 원격의료 플랫폼과 같은 디지털 헬스 솔루션의 통합, 감염증 진단에 차세대 염기서열 분석(NGS) 기술의 감염 인자를 신속하고 민감하게 검출하는 바이오센서 기술의 발전, 진단 플랫폼에 AI 및 머신러닝 알고리즘의 통합 등을 들 수 있습니다.
감염증 진단 검사 시장은 호흡기 감염증의 증가로 인해 성장이 예상됩니다. 호흡기 감염은 호흡기의 다양한 부위에 영향을 미치며, 밀접한 접촉, 비위생, 혼잡한 생활환경, 계절적 변화 등으로 인한 바이러스나 세균의 전파로 인해 발생합니다. 감염증의 진단 검사는 호흡기 감염증의 정확한 식별과 치료를 위해 매우 중요하며, 환자 검체에서 바이러스, 세균 등의 병원체를 정확하게 검출할 수 있습니다. 예를 들어, 캐나다 보건 정보 연구소에 따르면 급성 상기도 감염으로 인한 입원은 2022년 2,114건에서 2023년 2,797건으로 32% 증가했다고 보고했습니다.
감염증 진단 검사 시장의 주요 기업들은 경쟁력을 유지하기 위해 특히 분자진단 플랫폼의 기술 혁신에 집중하고 있습니다. 이러한 플랫폼은 진단 목적으로 생물학적 샘플에서 핵산을 검출 및 분석하기 위해 설계된 첨단 시스템입니다. 최근 벡톤딕킨슨앤컴퍼니는 최대 1,700개의 검체를 처리할 수 있고 24시간 이내에 결과를 얻을 수 있는 자동화 감염증 분자진단 플랫폼인 BD COR 시스템을 출시했습니다. 이 플랫폼은 분자 검사실의 워크플로우를 간소화하고 HPV, STI 등의 질병에 대한 효율성과 진단 정확도를 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 감염증 진단 검사 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 감염증 진단 검사 시장 : 성장률 분석
- 세계의 감염증 진단 검사 시장 실적 : 규모와 성장, 2019-2024
- 세계의 감염증 진단 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 감염증 진단 검사 전체 시장(TAM)
제6장 시장 세분화
- 세계의 감염증 진단 검사 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 분자진단 검사
- POC(Point of Care) 테스트(POCT) 감염증 진단 검사
- 세계의 감염증 진단 검사 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 호흡기
- 인간면역결핍바이러스(HIV)
- 헬스케어 관련 감염증(HAI)
- 성적인 건강
- 열대병
- 간
- 세계의 감염증 진단 검사 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 진단 검사실
- 병원과 진료소
- 학술조사기관
- 기타 최종사용자
- 세계의 감염증 진단 검사 시장, 분자진단 검사 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 중합효소 연쇄 반응(PCR) 검사
- 핵산 증폭 검사(NAAT)
- 차세대 시퀀싱(NGS)
- 마이크로어레이 기반 검사
- 세계의 감염증 진단 검사 시장, POC(Point of Care) 검사(POCT) 감염증 진단 검사 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 측방유동 어세이
- 신속 항원 검사
- 면역측정
- 휴대용 PCR
제7장 지역별·국가별 분석
- 세계의 감염증 진단 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 감염증 진단 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 감염증 진단 검사 시장 : 경쟁 구도
- 감염증 진단 검사 시장 : 기업 개요
- F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Becton Dickinson And Company
- Quest Diagnostics Incorporated
- Grifols S.A.
- Hologic Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Quidel Corporation
- Sysmex Corporation
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- DiaSorin SpA(Luminex)
- Myriad Genetics Inc.
- Seegene Inc.
- Ortho Clinical Diagnostics Inc.
- OraSure Technologies Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 감염증 진단 검사 시장 2029 : 새로운 기회를 제공하는 국가
- 감염증 진단 검사 시장 2029 : 새로운 기회를 제공하는 부문
- 감염증 진단 검사 시장 2029 : 성장 전략
제36장 부록
ksm
Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.
The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.
The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with an infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $38.52 billion in 2024 to $42.56 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.
The infectious disease diagnostics testing market size is expected to see rapid growth in the next few years. It will grow to $62.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, such as mobile apps and telemedicine platforms, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for rapid and sensitive detection of infectious agents, and integration of AI and machine learning algorithms into diagnostic platforms.
The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.
Leading companies in the infectious disease diagnostic testing market are focusing on innovation, particularly in molecular diagnostics platforms, to remain competitive. These platforms are sophisticated systems designed to detect and analyze nucleic acids from biological samples for diagnostic purposes. Becton Dickinson and Company recently launched the BD COR System, an automated infectious disease molecular diagnostics platform capable of high-throughput processing of up to 1,700 specimens with results delivered within 24 hours. This platform streamlines the molecular laboratory workflow, enhancing efficiency and diagnostic accuracy for diseases such as HPV and STIs.
In August 2022, SSI Diagnostica Group (SSID) acquired TechLab Inc., a US-based developer of infectious disease diagnostic products. This acquisition strengthens SSI Diagnostica Group's position in the infectious disease diagnostics market, aligning with their objectives of portfolio expansion, technological enhancement, and market share growth.
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Infectious Disease Diagnostics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
- 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases; Liver
- 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics; Academic Research Institutes; Other End-Users
- Subsegments:
- 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs); Next-Generation Sequencing (NGS); Microarray-Based Tests
- 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
- Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Infectious Disease Diagnostics Testing Market Characteristics
3. Infectious Disease Diagnostics Testing Market Trends And Strategies
4. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Infectious Disease Diagnostics Testing Growth Analysis And Strategic Analysis Framework
- 5.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Infectious Disease Diagnostics Testing Market Growth Rate Analysis
- 5.4. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM)
6. Infectious Disease Diagnostics Testing Market Segmentation
- 6.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Molecular Diagnostic Test
- Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
- 6.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Respiratory
- Human Immunodeficiency Virus (HIV)
- Healthcare Associated Infections (HAIs)
- Sexual Health
- Tropical Diseases
- Liver
- 6.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Laboratories
- Hospitals And Clinics
- Academic Research Institutes
- Other End-Users
- 6.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymerase Chain Reaction (PCR) Tests
- Nucleic Acid Amplification Tests (NAATs)
- Next-Generation Sequencing (NGS)
- Microarray-Based Tests
- 6.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lateral Flow Assays
- Rapid Antigen Tests
- Immunoassays
- Portable PCR
7. Infectious Disease Diagnostics Testing Market Regional And Country Analysis
- 7.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Infectious Disease Diagnostics Testing Market
- 8.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Infectious Disease Diagnostics Testing Market
- 9.1. China Infectious Disease Diagnostics Testing Market Overview
- 9.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Infectious Disease Diagnostics Testing Market
- 10.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Infectious Disease Diagnostics Testing Market
- 11.1. Japan Infectious Disease Diagnostics Testing Market Overview
- 11.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Infectious Disease Diagnostics Testing Market
- 12.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Infectious Disease Diagnostics Testing Market
- 13.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Infectious Disease Diagnostics Testing Market
- 14.1. South Korea Infectious Disease Diagnostics Testing Market Overview
- 14.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Infectious Disease Diagnostics Testing Market
- 15.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
- 15.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Infectious Disease Diagnostics Testing Market
- 16.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Infectious Disease Diagnostics Testing Market
- 17.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Infectious Disease Diagnostics Testing Market
- 18.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Infectious Disease Diagnostics Testing Market
- 19.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Infectious Disease Diagnostics Testing Market
- 20.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Infectious Disease Diagnostics Testing Market
- 21.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
- 21.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Infectious Disease Diagnostics Testing Market
- 22.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Infectious Disease Diagnostics Testing Market
- 23.1. North America Infectious Disease Diagnostics Testing Market Overview
- 23.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Infectious Disease Diagnostics Testing Market
- 24.1. USA Infectious Disease Diagnostics Testing Market Overview
- 24.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Infectious Disease Diagnostics Testing Market
- 25.1. Canada Infectious Disease Diagnostics Testing Market Overview
- 25.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Infectious Disease Diagnostics Testing Market
- 26.1. South America Infectious Disease Diagnostics Testing Market Overview
- 26.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Infectious Disease Diagnostics Testing Market
- 27.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Infectious Disease Diagnostics Testing Market
- 28.1. Middle East Infectious Disease Diagnostics Testing Market Overview
- 28.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Infectious Disease Diagnostics Testing Market
- 29.1. Africa Infectious Disease Diagnostics Testing Market Overview
- 29.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles
- 30.1. Infectious Disease Diagnostics Testing Market Competitive Landscape
- 30.2. Infectious Disease Diagnostics Testing Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
31. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies
- 31.1. Becton Dickinson And Company
- 31.2. Quest Diagnostics Incorporated
- 31.3. Grifols S.A.
- 31.4. Hologic Inc.
- 31.5. PerkinElmer Inc.
- 31.6. bioMerieux SA
- 31.7. Quidel Corporation
- 31.8. Sysmex Corporation
- 31.9. Bio-Rad Laboratories Inc.
- 31.10. QIAGEN N.V.
- 31.11. DiaSorin SpA (Luminex)
- 31.12. Myriad Genetics Inc.
- 31.13. Seegene Inc.
- 31.14. Ortho Clinical Diagnostics Inc.
- 31.15. OraSure Technologies Inc.
32. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market
34. Recent Developments In The Infectious Disease Diagnostics Testing Market
35. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies
- 35.1 Infectious Disease Diagnostics Testing Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Infectious Disease Diagnostics Testing Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Infectious Disease Diagnostics Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
